Emergent Biosolutions's total assets for Q2 2026 were $1.12B, a decrease of -15.42% from the previous quarter. CH:ER4 total liabilities were $775.40M for the fiscal quarter, a -2.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.